NASDAQ: KTRAKintara Therapeutics Inc Stock Ownership - Who owns Kintara Therapeutics?
Insider buying vs selling
Have Kintara Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when KTRA insiders and whales buy or sell their stock.
KTRA Shareholders
What type of owners hold Kintara Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Dennis M. Brown | 234.54% | 3,929,265 | $14.46M | Insider |
| William J. Garner | 144.76% | 2,425,207 | $8.92M | Insider |
| Howard K. Fuguet | 74.61% | 1,250,000 | $4.60M | Insider |
| Donald G. Bahouth | 62.23% | 1,042,500 | $3.84M | Insider |
| Raymond L. Vollintine | 60.62% | 1,015,500 | $3.74M | Insider |
| Robert E. Hoffman | 27.17% | 455,145 | $1.67M | Insider |
| John K. Bell | 21.80% | 365,139 | $1.34M | Insider |
| Anthony Scott Praill | 16.55% | 277,273 | $1.02M | Insider |
| John Liatos | 11.74% | 196,750 | $724.04k | Insider |
| Keith Murphy | 10.80% | 181,010 | $666.12k | Insider |
KTRA vs Biotech Stocks
Kintara Therapeutics Stock Ownership FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.